News: DURECT Corp (DRRX.OQ)
DRRX.OQ on NASDAQ Stock Exchange Global Market
1.27USD
2 Aug 2013
1.27USD
2 Aug 2013
Price Change (% chg)
$0.02 (+1.60%)
$0.02 (+1.60%)
Prev Close
$1.25
$1.25
Open
$1.25
$1.25
Day's High
$1.27
$1.27
Day's Low
$1.23
$1.23
Volume
10,050
10,050
Avg. Vol
121,323
121,323
52-wk High
$1.85
$1.85
52-wk Low
$0.61
$0.61
Select another date:
Tue, Apr 30 2013
Pain Therapeutics, Durect shares soar on Pfizer's Remoxy comments
- Shares of Pain Therapeutics Inc and Durect Corp rose more than 40 percent after partner Pfizer Inc said it is in talks with U.S. health regulators to find a way forward on the companies' painkiller, Remoxy.
Select another date:
- 5 Stocks Under $10 Set to Soar
- 4 Biotech Stocks Under $10 Making Big Moves
- FDA Decisions: Interesting Biotechnology Catalyst Events
- 4 Stocks Under $10 Making Big Moves
- FDA Accepts New Drug Application And Creates A Catalyst For Durect Corporation
- Alkermes Changing The Standard Of Care For Schizophrenia
Press Releases
- DURECT Announces Pricing of Public Offering of Common Stock
- DURECT to Participate in Upcoming Healthcare Conferences
- DURECT Corporation Announces Third Quarter 2012 Financial Results and Update of Programs
- DURECT Corporation Invites You to Join its Third Quarter 2012 Earnings Conference Call
- DURECT to Participate in Upcoming Healthcare Conferences
- DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
- DURECT Announces Intent to Submit NDA for POSIDURâ„¢ for Post-Operative Analgesia
- DURECT Corporation Invites You to Join its Second Quarter 2012 Earnings Conference Call
- DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
- DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology

